admin, Author at Life of Flow Podcast

🤔 15% No-Option Patients? #shorts

EPISODE 116 - “Delphi: The Global Consensus That's Changing How No-Option Patients Are Treated"" of the Life of Flow Podcast is now LIVE! Watch the full episode on the Life of Flow YouTube channel. Are we treating today’s patients with 30-year-old statistics? The landscape has changed. We’ve moved from treating smokers with aorto-iliac pathology to seeing much younger patients with severe diabetes and renal failure. What used to be labeled "no-option" doesn't have to be the standard anymore. In this new episode with Dr. Alejandro Fabiani, we explore how the limits of intervention are being pushed and how global consensus is creating opportunities where there used to be none. Watch it now in our channel.

admin2026-04-30T15:12:27+00:00April 29, 2026|Shorts|

🫩 Burnout Is Not A Badge #shorts

Stress isn't your enemy. It can build resilience and improve performance. But only if it stops. When stress becomes constant, with no space for recovery, it becomes burnout instead. The latest Life Of Flow's episode with Lauren Colletti is out now. Check out our channel to watch it.

admin2026-04-27T14:28:26+00:00April 25, 2026|Shorts|

Delphi: The Global Consensus That’s Changing How No-Option Patients Are Treated | LOF #116

In this episode of Life of Flow, we sit down with Dr. Mario Alejandro Fabiani to explore a question that directly impacts clinical decision-making: what does a “no option” patient mean? From that starting point, Dr. Fabiani leads an international consensus aimed at bringing structure to a definition that currently varies depending on the physician, their experience, and their clinical context. The conversation also highlights how patient profiles have shifted over time, why commonly cited percentages may not reflect today’s reality, and how these assumptions influence decisions such as attempting revascularization or proceeding with amputation. Toward the end, the focus turns to the need to validate and adopt this consensus in real-world practice. 03:32 From critique to action: building evidence 04:00 Forming an international Delphi consensus 05:09 What a Delphi is and how it works 08:51 Why the “no option” definition needs to change 12:23 The debate around the 15% “no option” figure 14:51 How patient profiles have changed over time 17:26 Geographic variation in cases and decision-making 20:22 Presentation of the Delphi consensus 39:53 Real-world amputation outcomes in Latin America Who Should Listen Vascular surgeons, trainees, and clinicians managing complex patients who want to better understand how the definition of “no option” impacts real-world decision-making. About Dr. Mario Alejandro Fabiani Dr. Mario Alejandro Fabiani is a physician trained at the National University of La Plata (Argentina). He completed his residency in General Surgery and served as Chief Resident at CEMIC in Buenos Aires. He then pursued a second specialty in Vascular Surgery and Transplant through a joint program between CEMIC and the Hospital de Clínicas at the University of Buenos Aires. He received scholarships from the Bunge y Born Foundation to attend Yale University and from the Argentine Association of Angiology to train at the Vascular Surgery Service at NYU Medical Center. He later joined the Vascular Surgery and Transplant Service at CEMIC, where he was involved in teaching until 2013. Since then, he has been a full-time professor at Tecnológico de Monterrey. He is Director of the Vascular Medicine Center at Sociedad Académica Temperantia, has participated in hundreds of national and international conferences, pioneered endovascular techniques, and trained dozens of specialists. He is an honorary professor at the University of Valladolid, an honorary member of medical societies in Colombia and Ecuador, and a Level I member of Mexico’s National System of Researchers. With over 25 years of experience, he is one of the most experienced specialists in Mexico in the management of aortic, carotid, and peripheral arterial disease. This episode references the international consensus led by Dr. Fabiani to redefine the “no option” patient. You can access the full document here: academic.oup.com/bjs/advance-article-abstract/doi/10.1093/bjs/znag040/8606833 Connect with Dr. Mario Alejandro Fabiani 💼 LinkedIn: Mario Alejandro Fabiani 🔗 Website: drfabiani.com/ Follow Life of Flow 📲 Instagram: @LifeofFlowPodcast 👍 Facebook: Life of Flow Podcast 💼 LinkedIn: Life of Flow Podcast 🐦 X: @VascularPodcast If this conversation changed how you think about what it really means for a patient to be “no option,” the decisions made before recommending amputation, and the importance of questioning long-held assumptions in clinical practice, share it with a colleague who would benefit from it. A quick review also helps more physicians and interventionists discover conversations like this.

admin2026-04-24T23:20:16+00:00April 24, 2026|Videos|

💊 I Started Peptides And Felt 20 Again #shorts

New tools change how patients experience their own physiology. When continuous data from a glucose monitor is combined with targeted interventions like peptides, the shift can happen so quickly it almost feels like a placebo. The effect is real, but it raises a great question: how should these results be interpreted in a clinical context? Listen to the full conversation in our latest episode with Lauren Colletti. Available now on Life Of Flow's channel.

admin2026-04-27T14:28:31+00:00April 24, 2026|Shorts|

🖥️ Your New Doctor Is ChatGPT? #shorts

AI can now give you more data than a routine check-up, and still miss a heart attack on a standard EKG. Do you really want ChatGPT as your doctor? Our latest episode with Lauren Colletti is out now - and we go deeper into where AI fits in care, what it still gets wrong, and why clinical judgment remains essential. Visit Life Of Flow's channel and watch it now.

admin2026-04-23T16:32:16+00:00April 23, 2026|Shorts|

🤒 Peptides Target Disease Before It Starts #shorts

EPISODE 115 - “Can Peptides Really Heal Your Wounds Faster Than Surgery?” of the Life of Flow Podcast is now LIVE! 👉 Visit the Life of Flow channel to watch it. Biohacking or medicine? Most disease is the result of inflammation building up over time. ...and peptides target the pathways tied to repair, recovery, and immune function. So, how do we apply them? and where do they fit in clinical care? In week's episode of Life of Flow, Lauren Colletti breaks down how she integrates these therapies into a structured clinical approach. Watch it on our channel.

admin2026-04-23T16:32:20+00:00April 22, 2026|Shorts|

🔬 The Science Behind Reflow’s Spur System #shorts

Can you get the benefits of a stent without leaving one behind? That’s the core idea of Reflow Medical's retrievable scaffolding technology: a revolutionary device for patients with BTK disease. The answer might be on controlled plaque disruption, and how it could help durability in BTK revascularization. The latest episode of Life of Flow with Dr. Anahita Dua is now available. Check it out on our channel.

admin2026-04-20T19:02:35+00:00April 18, 2026|Shorts|

🤔 How Reflow Changes BTK Strategy #shorts

Peripheral vascular disease doesn’t look the same as it did 30 years ago. Patients are living longer with diabetes, hypertension, and vascular disease, leading to more complex disease below the knee. But there's a device challenging standard balloon angioplasty: This is how the Reflow Medical's Retrievable Spur Stent System works. Listen to the full conversation in the latest Life of Flow's episode with Dr. Anahita Dua. Visit our channel now.

admin2026-04-20T19:02:39+00:00April 17, 2026|Shorts|

👨‍⚕️ How Patients Are Getting Results That Last #shorts

One of the biggest frustrations in limb salvage interventions is recoil. You open the vessel with POBA, and minutes later, you’re watching the lumen narrow again. For surgeons treating CLI, durability is key. Dr. Anahita Dua explains how she evaluates a new endovascular approach, and how Reflow Medical's Retrievable Spur Stent System addresses the instant stenosis often seen after POBA. Episode out now. Visit Life Of Flow's channel.

admin2026-04-17T14:27:23+00:00April 16, 2026|Shorts|

💡 A Stent Effect Without Leaving Metal Behind #shorts

EPISODE 114 - “Why Reflow Medical’s Spur System Is Changing BTK Treatment” of the Life of Flow Podcast is now LIVE! Watch the full episode on the Life of Flow YouTube channel. Durability remains one of the biggest challenges in BTK interventions. Permanent stents can help with recoil, but they also introduce new concerns - especially in delicate tibial vessels. So, what if you could get the scaffolding effect of a stent, without leaving an implant behind? This week on Life of Flow, Dr. Anahita Dua discusses evolving strategies for treating BTK disease and how new technologies aim to improve long-term vessel patency. Full episode out now on our channel.

admin2026-04-15T16:44:10+00:00April 15, 2026|Shorts|

About admin